External quality assessment (EQA) is a process in which multiple laboratories analyze the same specimen, and the results reported by the laboratories are collected and fed back by an external independent organization to evaluate laboratory operations. Interlaboratory comparisons are used to determine a laboratory’s ability to calibrate, detect, and monitor its ongoing capabilities. The results of inter-laboratory quality assessment are objective standards for testing laboratory quality and an important basis for testing quality evaluation. Inter-laboratory quality assessment at the national and provincial levels is an important inter-laboratory quality assessment standard in China. Participating in and passing the national and provincial inter-laboratory quality assessment means that the accuracy and stability of the inspection results of the inspection agency have been recognized by the authority.
According to Article 28 of the “Administrative Measures for Clinical Laboratories of Medical Institutions”, clinical laboratories of medical institutions shall participate in the inter-laboratory quality evaluation of clinical laboratories organized by the inter-laboratory quality evaluation institutions recognized by the Ministry of Health. The national inter-laboratory quality evaluation organized by the National Health Commission’s Clinical Inspection Center is the most authoritative in China. In addition, the recognized clinical inspection centers of the provincial health departments are also OK.
Zhongxiu Technology CRP Inflammation Project participated in the 2021 Guizhou Inter-laboratory Quality Assessment Activities, and the results passed with full marks! This evaluation once again proved the standardization, accuracy, reliability and stability of Zhongxiu Technology in the experimental process, as well as its high technical strength and high-quality system level in the field of biological sample analysis.
Zhongxiu Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbiological series, biochemical series immune series and other reagents and supporting instruments.
The company has a scientific and perfect management system, a national standard purification workshop, and a fully functional inspection center. On this basis, the company will continue to invest in research and development to accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, and improve product quality to provide customers with safe and effective in vitro diagnostic products.
The company has always adhered to the core concept of “fast and accurate, living up to life”, and is committed to providing excellent products and services to the society and contributing to the cause of human health.